Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.67 |
| ▸ | NR4A2 | P43354 | 3/20 | 0.62 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.62 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.62 |
| ▸ | TP53 | P04637 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | CA1 | P00915 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 1/20 | 0.58 |
| ▸ | RXRA | P19793 | 3/20 | 0.56 |
| ▸ | RXRB | P28702 | 3/20 | 0.56 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8123793 | 0.87 | CA1 (0.61) | PKMNR4A2NR4A1NR4A3TP53 | |
| SCHEMBL155030 | 0.87 | CA1 (0.61) | PKMNR4A2NR4A1NR4A3TP53 | |
| SCHEMBL196110 | 0.86 | PKM (0.88) | PKMNR4A2NR4A1NR4A3TP53 | |
| SCHEMBL12940638 | 0.86 | PLA2G4B (0.64) | PKMNR4A2NR4A1NR4A3TP53 | |
| SCHEMBL118037 | 0.84 | PKM (0.77) | PKMTP53TSHRPLA2G4BMAPK1 | |
| SCHEMBL1952122 | 0.84 | TP53 (0.79) | PKMTP53TSHRPLA2G4BMAPK1 | |
| SCHEMBL5914350 | 0.84 | PKM (0.64) | PKMNR4A2NR4A1NR4A3TP53 | |
| SCHEMBL18319953 | 0.82 | CA1 (0.55) | PKMNR4A2NR4A1NR4A3TP53 | |
| SCHEMBL2181009 | 0.82 | TP53 (0.82) | PKMTP53TSHRPLA2G4BPOLB | |
| SCHEMBL2180731 | 0.82 | TP53 (0.82) | PKMTP53TSHRPLA2G4BPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 420 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4242257-B1 | POLYMER-CLAY COMPOSITE AND ORGANOCLAY | UNIV SOUTHAMPTON (GB) | 2025-07-02 | — | — | EP | claimed |
| EP-4493149-A2 | METHODS FOR MARKING A TARGET LOCATION FOR A MEDICAL PROCEDURE | Ephemeral Solutions, Inc. (US) | 2025-01-22 | — | — | EP | claimed |
| US-20250009843-A1 | COMPOSITIONS AND METHODS FOR TREATMENTS BY MODULATION OF EXCITABLE TISSUES ACTIVITIES, AND FOR ANTIMICROBIAL APPLICATIONS | NAT UNIVESITY OF IRELAND GALWAY (IE) | 2025-01-09 | — | — | US | claimed |
| US-20240350707-A1 | TISSUE SCAFFOLD AND SCAFFOLD COMPOSITION | LOCATE BIO LIMITED (GB) | 2024-10-24 | — | — | US | claimed |
| WO-2024211384-A1 | EGG BASED MICROCARRIERS AND SCAFFOLDS FOR CELLULAR AGRICULTURE AND OTHER APPLICATIONS | HATCHLESS INC. (US) | 2024-10-10 | — | — | WO | claimed |
| US-11904070-B2 | Tissue scaffold and scaffold composition | LOCATE THEAPEUTICS LIMITED (GB) | 2024-02-20 | — | — | US | claimed |
| EP-4291136-A1 | PARTICLES CONTAINING COLORING AGENTS AND METHODS OF USING THE SAME | Ephemeral Solutions, Inc. (US) | 2023-12-20 | — | — | EP | claimed |
| US-20230398058-A1 | PARTICLES CONTAINING COLORING AGENTS AND METHODS OF USING THE SAME | EPHEMERAL SOLUTIONS, INC. | 2023-12-14 | — | — | US | claimed |
| WO-2023178213-A2 | METHODS FOR MARKING A TARGET LOCATION FOR A MEDICAL PROCEDURE | EPHEMERAL SOLUTIONS, INC. (US) | 2023-09-21 | — | — | WO | claimed |
| EP-4242257-A1 | POLYMER-CLAY COMPOSITE AND ORGANOCLAY | University Of Southampton (GB) | 2023-09-13 | — | — | EP | claimed |
| US-5902599-A | PHOTOPOLYMERIZING ANHYDRIDE MONOMERS OR OLIGOMERS HAVING UNSATURATION FOR CROSSLINKING; POLYANHYDRIDES HAVING GOOD PROCESSIBILITY, STRENGTH AND MECHANICAL PROPERTIES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1999-05-11 | — | — | US | claimed |
| EP-0912166-A1 | METHODS AND COMPOSITIONS FOR ENHANCING THE BIOADHESIVE PROPERTIES OF POLYMERS USING ORGANIC EXCIPIENTS | BROWN UNIVERSITY RESEARCH FOUNDATION (US) | 1999-05-06 | — | — | EP | claimed |
| WO-1997049385-A1 | METHODS AND COMPOSITIONS FOR ENHANCING THE BIOADHESIVE PROPERTIES OF POLYMERS USING ORGANIC EXCIPIENTS | BROWN UNIVERSITY RESEARCH FOUNDATION (US) | 1997-12-31 | — | — | WO | claimed |
| EP-0746342-A1 | BIODEGRADABLE CONTROLLED RELEASE MELT-SPUN DELIVERY SYSTEM | FUISZ TECHNOLOGIES LTD. (US) | 1996-12-11 | — | — | EP | claimed |
| EP-0568651-A4 | BIODEGRADABLE POLYMER BLENDS FOR DRUG DELIVERY | NOVA PHARM CORP (US) | 1996-11-27 | — | — | EP | claimed |
| US-5518730-A | Biodegradable controlled release flash flow melt-spun delivery system | FUISZ TECHNOLOGIES LTD. (US) | 1996-05-21 | — | — | US | claimed |
| EP-0746342-A4 | BIODEGRADABLE CONTROLLED RELEASE MELT-SPUN DELIVERY SYSTEM | FUISZ TECHNOLOGIES LTD (US) | 1996-01-11 | — | — | EP | claimed |
| WO-1993024154-A1 | BIODEGRADABLE CONTROLLED RELEASE MELT-SPUN DELIVERY SYSTEM | FUISZ TECHNOLOGIES, LTD. (US) | 1993-12-09 | — | — | WO | claimed |
| EP-0568651-A1 | BIODEGRADABLE POLYMER BLENDS FOR DRUG DELIVERY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1993-11-10 | — | — | EP | claimed |
| WO-1992013567-A1 | BIODEGRADABLE POLYMER BLENDS FOR DRUG DELIVERY | NOVA PHARMACEUTICAL CORPORATION (US) | 1992-08-20 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230398058-A1 | PARTICLES CONTAINING COLORING AGENTS AND METHODS OF USING THE SAME | LDHA, CUTA, LIPA | PKM 1284/4885NR4A2 3741/4885NR4A1 3745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.